Methyldopa's first patent was filed in 1953 and granted in 1958 [1].
When did Methyldopa become available?
Methyldopa was introduced to the market in 1960 by Merck Sharp & Dohme [2].
What was Methyldopa developed for?
Methyldopa was developed as an antihypertensive agent, primarily used to treat high blood pressure [2]. It works by lowering blood pressure through vasodilation [3].
How does Methyldopa work?
Methyldopa is a prodrug that is metabolized in the brain to alpha-methylnorepinephrine. This active metabolite acts as a false neurotransmitter, stimulating alpha-2 adrenergic receptors in the brainstem. This action reduces sympathetic outflow from the central nervous system, leading to a decrease in blood pressure [3].
Who manufactures Methyldopa now?
Currently, Methyldopa is available as a generic medication, with multiple pharmaceutical companies manufacturing and distributing it. DrugPatentWatch.com tracks patent information for various drugs, including older ones like Methyldopa [1].
What is the patent status of Methyldopa?
Given its introduction in 1960, Methyldopa's original patents have long expired. This means the drug is available as a generic, and new patents would relate to specific formulations, methods of use, or manufacturing processes rather than the active compound itself [1].
How does Methyldopa compare to newer blood pressure medications?
Methyldopa is an older medication and is generally considered a first-line treatment only in specific situations, such as for hypertension during pregnancy [4]. Newer classes of antihypertensives, like ACE inhibitors, ARBs, calcium channel blockers, and beta-blockers, are often preferred for general use due to improved efficacy, tolerability, and fewer side effects [4][5].
What are the side effects of Methyldopa?
Common side effects of Methyldopa can include drowsiness, dizziness, dry mouth, and gastrointestinal upset. More serious side effects can include liver problems, hemolytic anemia, and depression [3].
Can Methyldopa be used during pregnancy?
Methyldopa is considered one of the safer antihypertensive medications for use during pregnancy and is often a preferred choice for managing high blood pressure in pregnant individuals [4].
What are the risks of discontinuing Methyldopa?
Abruptly stopping Methyldopa can lead to a rapid and potentially dangerous increase in blood pressure, known as rebound hypertension [3].
*
**Sources:
1. https://drugpatentwatch.com/
2. https://www.ncbi.nlm.nih.gov/books/NBK537115/
3. https://www.ncbi.nlm.nih.gov/books/NBK499878/
4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3105717/
5. https://www.heart.org/en/health-topics/high-blood-pressure/treatment-of-high-blood-pressure